HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.

Abstract
Schistosomiasis is caused by several worm species of the genus Schistosoma and afflicts up to 600 million people in 74 tropical and sub-tropical countries in the developing world. Present disease control depends on treatment with the only available drug praziquantel. No vaccine exists despite the intense search for molecular candidates and adjuvant formulations over the last three decades. Cysteine peptidases such as papain and Der p 1 are well known environmental allergens that sensitize the immune system driving potent Th2-responses. Recently, we showed that the administration of active papain to mice induced significant protection (P<0.02, 50%) against an experimental challenge infection with Schistosoma mansoni. Since schistosomes express and secrete papain-like cysteine peptidases we reasoned that these could be employed as vaccines with inbuilt adjuvanticity to protect against these parasites. Here we demonstrate that sub-cutaneous injection of functionally active S. mansoni cathepsin B1 (SmCB1), or a cathepsin L from a related parasite Fasciola hepatica (FhCL1), elicits highly significant (P<0.0001) protection (up to 73%) against an experimental challenge worm infection. Protection and reduction in worm egg burden were further increased (up to 83%) when the cysteine peptidases were combined with other S. mansoni vaccine candidates, glyceraldehyde 3-phosphate dehydrogenase (SG3PDH) and peroxiredoxin (PRX-MAP), without the need to add chemical adjuvants. These studies demonstrate the capacity of helminth cysteine peptidases to behave simultaneously as immunogens and adjuvants, and offer an innovative approach towards developing schistosomiasis vaccines.
AuthorsRashika El Ridi, Hatem Tallima, Sahar Selim, Sheila Donnelly, Sophie Cotton, Bibiana Gonzales Santana, John P Dalton
JournalPloS one (PLoS One) Vol. 9 Issue 1 Pg. e85401 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24465551 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Helminth
  • Antigens, Helminth
  • Recombinant Proteins
  • Vaccines, Subunit
  • Peroxiredoxins
  • Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)
  • Cathepsins
  • Cathepsin B
  • cathepsin S
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antibodies, Helminth (biosynthesis)
  • Antigens, Helminth (chemistry, immunology)
  • Cathepsin B (chemistry, immunology)
  • Cathepsins (chemistry, immunology)
  • Fasciola hepatica (chemistry, enzymology)
  • Female
  • Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) (chemistry, immunology)
  • Immunity, Active (drug effects)
  • Mice
  • Peroxiredoxins (chemistry, immunology)
  • Pichia (genetics, metabolism)
  • Recombinant Proteins (chemistry, immunology)
  • Schistosoma mansoni (chemistry, enzymology, immunology)
  • Schistosomiasis mansoni (immunology, prevention & control)
  • Vaccination
  • Vaccines, Subunit (administration & dosage, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: